Article info
Ovarian Cancer
Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
- Address correspondence and reprint requests to Mingchen Ba, PhD, Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, Guangzhou 510095, China. E-mail: bamingchen0713{at}163.com; Hui Long, PhD, Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, Guangzhou 510095, China. E-mail: 798587414{at}qq.com.
Citation
Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
Publication history
- Received December 13, 2015
- Accepted July 4, 2016
- First published November 1, 2016.
Online issue publication
November 01, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.